Kiran Mazumdar-Shaw urges IPO reforms, saying India’s listing norms hinder biotech firms that need long R&D cycles before generating revenueKiran Mazumdar-Shaw urges IPO reforms, saying India’s listing norms hinder biotech firms that need long R&D cycles before generating revenue Latest News [ SOBAN NEWS: International and National ]